How Much Does Hodgkin's lymphoma Treatment Cost in Ramat Gan?
| Israel | Turkey | Austria | |
|---|---|---|---|
| Radiation therapy for colorectal cancer | ≈ $14,000 | from $6,000 | from $6,600 |
| Immunotherapy with Keytruda (Pembolizumab) | ≈ $4,800 | from $2,800 | ≈ $5,800 |
| Chemotherapy for breast cancer | ≈ $6,500 | from $4,700 | ≈ $9,500 |
| Chemotherapy | from $1,200 | from $1,000 | from $990 |
| Biological therapy | ≈ $9,000 | ≈ $2,500 | ≈ $7,500 |
Your Benefits and Guarantees with Bookimed
Transparent Prices & Flexible Installments
No hidden fees – just official clinic prices. Pay at the clinic for Hodgkin's lymphoma treatment and use a flexible installment plan if needed.
Verified Clinics & Doctors Only
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Hodgkin's lymphoma treatment and have the necessary licenses to serve international patients worldwide.
Free 24/7 Assistance
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Hodgkin's lymphoma treatment journey.

Your personal Bookimed medical coordinator
- Supports you at every stage
- Helps choose the right clinic and doctor
- Ensures quick and convenient access to information
Best Hodgkin's lymphoma Hospitals in Ramat Gan: 1 Verified Option and Prices
Get a Medical Assessment for Hodgkin's lymphoma Treatment in Ramat Gan: Consult with 8 Experienced Doctors Now
View all Doctors
Amos Toren
Dr. Amos Toren is a pediatric hemato-oncologist at Sheba Medical Center. He served as Director of the Pediatric Hemato-Oncology and Bone Marrow Transplant Division. Dr. Toren holds a PhD in Human Genetics. He specializes in CAR T-cell therapy and bone marrow transplantation for children. Forbes Israel has recognized his expertise in hematology.
- Served as the Head of the Hematology Division at Tel Aviv University.
- Treats complex cases of leukemia, lymphoma, and rare pediatric cancers.
- Member of the American Society of Hematology and European Group for Blood and Marrow Transplantation.
- Collaborates on research with the NIH and St. Jude Children’s Research Hospital.

Hana Golan
Dr. Hana Golan heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation Division at Sheba Medical Center. She specializes in high-risk pediatric tumors and complex childhood cancers. Dr. Golan serves as the principal investigator for the High-Risk Neuroblastoma ESIOP protocol. She practices at a hospital ranked among the global top 10 by Newsweek.
- National coordinator of multicenter oncology protocols and international Phase I/II clinical trials.
- Performs bone marrow transplants and CAR T-cell therapy for pediatric patients.
- Expert in neuroblastoma, leukemia, and treatment-resistant malignancies.
- Senior Lecturer at the Sackler Faculty of Medicine at Tel Aviv University.

Hila Magen
Dr. Hila Magen is a leading Israeli hemato-oncologist at Sheba Medical Center. She heads the Multiple Myeloma and Amyloidosis Unit. Dr. Magen specializes in treating complex plasma cell disorders and high-risk myeloma. She is a principal investigator for innovative point-of-care CAR-T therapy programs. Her work brings advanced immunotherapies into routine clinical care.
- Authored over 100 scientific publications and landmark myeloma studies.
- Completed fellowships at MD Anderson and University of Arkansas for Medical Sciences.
- Performs CAR-T cell therapy and bone marrow transplantations.
- Works at Sheba Medical Center, ranked 7th worldwide in 2026 by Newsweek.

Elad Jacoby
Dr. Elad Jacoby is a pioneer of pediatric CAR T–cell therapy in Israel. He heads the Pediatric Cell Therapy Center at Sheba Medical Center. Dr. Jacoby specializes in treating relapsed and high-risk pediatric leukemias and lymphomas. He completed fellowships at Johns Hopkins and the U.S. National Cancer Institute.
- Medical Director of the Advanced Biotherapy Center at Sheba Medical Center.
- Authored over 240 scientific publications in pediatric hemato-oncology.
- Board-certified in both Pediatrics and Pediatric Hematology and Oncology.
- Leads the integration of CAR T–cell therapy with bone marrow transplantation.
Reviews about Bookimed: Discover Patients' Insights
All reviewsShare this content
Anna Leonova












